Glossary

SGLT2 Inhibitor

Also known as: SGLT2i, dapagliflozin, empagliflozin

A class of medications that inhibit renal glucose reabsorption, used in diabetes and heart failure with proven benefits on heart failure hospitalization and renal outcomes.

Related topics